Benefits
Body weight and BMI reduction
Briskey 2022 (6-month RCT, ITT n=136) showed 4.2% body weight reduction with Morosil vs 2.2% placebo (p=0.015) and significant BMI improvement (p=0.019). Cardile 2015 (12-week RCT, n=60) reported significant reductions in body weight, BMI, waist and hip circumference vs placebo. The Campos 2025 meta-analysis (3 RCTs, n=252) calculated a pooled mean difference of -2.08 kg body weight (95% CI -3.50 to -0.67, p<0.01) and -1.53 kg fat mass (p=0.03).
Waist and hip circumference
Briskey 2022 found waist circumference reductions of 3.9 cm in active group vs 1.7 cm placebo (p=0.017) and hip circumference 3.4 cm vs 2.0 cm (p=0.049). Improvements in central adiposity were a consistent finding across both pivotal RCTs.
Reduced visceral and subcutaneous fat
DXA-measured fat distribution improved significantly in the Morosil group in Briskey 2022 — visceral fat p=0.018, subcutaneous fat p=0.006, total fat mass p=0.012. This suggests the extract preferentially affects metabolically active fat depots.
Antioxidant phytocomplex
Anthocyanin content (~140 mg/L in Moro juice) — particularly cyanidin 3-glucoside — provides robust antioxidant capacity. Hydroxycinnamic acids and flavone glycosides contribute additional radical-scavenging activity beyond what's expected from vitamin C alone.
Mechanism of action
Inhibits adipogenesis
Red orange standardized extract inhibits 3T3-L1 preadipocyte differentiation by downregulating adipogenic gene expression and modulating adiponectin secretion and leptin release. This affects the formation of new fat cells rather than just shrinking existing ones.
PPAR-α activation and lipid homeostasis
Salamone 2012 (mouse model) found Moro juice exerts hepatoprotective effects via changes in expression of enzymes involved in lipid homeostasis — the proposed mechanism is promotion of lipolysis and lipid peroxidation through PPAR-α induction with simultaneous suppression of lipogenesis via Liver X Receptor downregulation.
Anthocyanin-mediated metabolic modulation
Cyanidin 3-glucoside influences antioxidant, anti-inflammatory, and metabolic pathways. Animal studies show anthocyanin-rich Moro juice limits body weight gain, enhances insulin sensitivity, and decreases serum triglycerides and total cholesterol — even when overall energy intake is not reduced.
Clinical trials
Single-site, double-blind, randomized, placebo-controlled study (Briskey, Malfa, Rao 2022, Nutrients 14(3):427). Conducted in Brisbane, Australia between November 2018 and June 2020.
Overweight but otherwise healthy adults aged 20-65 years. ITT analysis: n=136 (active n=65, placebo n=71). All participants combined supplementation with calorie-controlled diet and exercise.
After 6 months: body mass 4.2% reduction vs 2.2% placebo (p=0.015), BMI improvement (p=0.019), hip circumference 3.4 vs 2.0 cm reduction (p=0.049), waist 3.9 vs 1.7 cm (p=0.017), fat mass (p=0.012), visceral fat (p=0.018), subcutaneous fat (p=0.006). Liver toxicity safety markers stayed within normal range throughout. Effects emerged at month 3 and continued through month 6.
Randomized, placebo-controlled, double-blind trial (Cardile, Graziano, Venditti 2015, Natural Product Research 29(24):2256-2260, doi:10.1080/14786419.2014.1000897). The first dedicated human trial of Morosil® standardized extract.
60 overweight healthy adult volunteers (BMI 25-35), aged 20-65. Randomized to Morosil 400 mg/day or placebo for 12 weeks.
Significant reduction in BMI within 4 weeks (p<0.05). At 12 weeks, body weight, BMI, waist and hip circumference were all significantly different from placebo group. No significant changes occurred in placebo group at any time point. Established the foundational clinical evidence for Morosil branded extract.
PRISMA systematic review and meta-analysis searching PubMed, Embase, and Cochrane (Campos, Ruelas, da Silva, de Lima, Holanda 2025).
3 RCTs included, total 252 overweight and obese adult participants. Studies conducted in Italy, Australia, and Brazil with 400 mg/day Morosil extract or 0.5–1 g Citrus sinensis dried extract.
Moro orange juice extract significantly reduced body weight by 2.08 kg vs placebo (95% CI -3.50 to -0.67, I²=0%, p<0.01) and fat mass by 1.53 kg (95% CI -2.92 to -0.15, I²=0%, p=0.03). Waist circumference showed heterogeneous results (-3.25 cm, I²=99%, p=0.05). No significant effects on lean mass. GRADE assessment showed low to very low certainty of evidence. Authors concluded Moro orange extract may result in weight and fat mass reduction in overweight/obese adults.
About this ingredient
Morosil® is a standardized solid extract obtained from the juice of Sicilian Moro red blood oranges (Citrus sinensis L. Osbeck — Moro cultivar) grown around Mount Etna. The branded ingredient is manufactured by Bionap (Italy) using a proprietary process that preserves the natural composition of anthocyanins (predominantly cyanidin 3-glucoside, average ~140 mg/L in Moro juice), hydroxycinnamic acids (caffeic, ferulic, sinapic acid derivatives), flavone glycosides (hesperidin, narirutin), and ascorbic acid.
Unlike conventional sweet oranges, Moro oranges have a deep red flesh due to the high anthocyanin content — pigments not normally found in other citrus fruits. The extract is delivered as a dry powder typically encapsulated at the 400 mg studied dose. EVIDENCE: Three published RCTs (Cardile 2015, Briskey 2022, Kegele 2019) and the Campos 2025 meta-analysis support body composition benefits at 400 mg/day for 12 weeks to 6 months.
Effects emerge as early as 4 weeks for BMI but most outcomes require ≥3 months. Best results occur when paired with a calorie-controlled diet and physical activity. SAFETY: All published trials have shown liver safety parameters within normal range.
Generally well-tolerated; citrus allergy is the main contraindication. The Campos 2025 meta-analysis flagged GRADE certainty as low-to-very-low due to small trial count, manufacturer-affiliated studies, and methodological concerns — so position as a complementary lifestyle aid rather than a standalone weight-loss intervention.